{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:57:19Z","timestamp":1790477839996,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2013.02.051","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T06:31:13Z","timestamp":1363156273000},"page":"2130-2136","source":"Crossref","is-referenced-by-count":73,"title":["Identification of conserved neutralizing linear epitopes within the VP1 protein of coxsackievirus A16"],"prefix":"10.1016","volume":"31","author":[{"given":"Jinping","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xulin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2 Aug 1","key":"10.1016\/j.vaccine.2013.02.051_bib0005","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1006\/viro.1994.1423","article-title":"Molecular analysis of coxsackievirus A16 reveals a new genetic group of enteroviruses","volume":"202","author":"Poyry","year":"1994","journal-title":"Virology"},{"issue":"Apr (7)","key":"10.1016\/j.vaccine.2013.02.051_bib0010","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1128\/JVI.07174-11","article-title":"Toward genetics-based virus taxonomy: comparative analysis of a genetics-based classification and the taxonomy of picornaviruses","volume":"86","author":"Lauber","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2013.02.051_bib0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1743-422X-8-534","article-title":"Construction and characterization of an infectious clone of coxsackievirus A16","volume":"8","author":"Liu","year":"2011","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.vaccine.2013.02.051_bib0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00705-006-0934-5","article-title":"Molecular phylogeny of modern coxsackievirus A16","volume":"152","author":"Perera","year":"2007","journal-title":"Arch Virol"},{"issue":"Feb (2)","key":"10.1016\/j.vaccine.2013.02.051_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/JCM.02338-09","article-title":"Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China","volume":"48","author":"Zhang","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"Mar (Pt 3)","key":"10.1016\/j.vaccine.2013.02.051_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1099\/jmm.0.025056-0","article-title":"Molecular characterization of enterovirus 71 and coxsackievirus A16 using the 5\u2032 untranslated region and VP1 region","volume":"60","author":"Zhou","year":"2011","journal-title":"J Med Microbiol"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2013.02.051_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/JCM.00718-06","article-title":"Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003","volume":"45","author":"Hosoya","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"2 Feb","key":"10.1016\/j.vaccine.2013.02.051_bib0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"Feb (1)","key":"10.1016\/j.vaccine.2013.02.051_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00430-009-0133-6","article-title":"Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany","volume":"199","author":"Rabenau","year":"2010","journal-title":"Med Microbiol Immunol"},{"issue":"Apr (2)","key":"10.1016\/j.vaccine.2013.02.051_bib0050","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11262-009-0440-4","article-title":"Detection of non-polio enteroviruses in Hungary 2000-2008 and molecular epidemiology of enterovirus 71, coxsackievirus A16, and echovirus 30","volume":"40","author":"Kapusinszky","year":"2010","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2013.02.051_bib0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"issue":"Dec (12)","key":"10.1016\/j.vaccine.2013.02.051_bib0060","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00006454-199912000-00013","article-title":"Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998","volume":"18","author":"Chang","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"Oct (8)","key":"10.1016\/j.vaccine.2013.02.051_bib0065","first-page":"615","article-title":"Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957; isolation of group A Coxsackie virus","volume":"79","author":"Robinson","year":"1958","journal-title":"Can Med Assoc J"},{"issue":"Feb (1)","key":"10.1016\/j.vaccine.2013.02.051_bib0070","first-page":"38","article-title":"Coxsackieviruses infection in northern Taiwan--epidemiology and clinical characteristics","volume":"42","author":"Yen","year":"2009","journal-title":"J Microbiol Immunol Infect"},{"issue":"Oct (10)","key":"10.1016\/j.vaccine.2013.02.051_bib0075","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1510.090594","article-title":"Rhombencephalitis and coxsackievirus A16","volume":"15","author":"Goto","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2013.02.051_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2013.02.051_bib0085","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"May","key":"10.1016\/j.vaccine.2013.02.051_bib0090","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(63)80047-5","article-title":"Myocarditis possibly due to Coxsackie group A, type 16, virus","volume":"62","author":"Goldberg","year":"1963","journal-title":"J Pediatr"},{"issue":"May","key":"10.1016\/j.vaccine.2013.02.051_bib0095","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright","year":"1963","journal-title":"N Engl J Med"},{"issue":"Jul (7)","key":"10.1016\/j.vaccine.2013.02.051_bib0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3201\/eid1307.070295","article-title":"Fatal coxsackievirus A-16 pneumonitis in adult","volume":"13","author":"Legay","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"Sep","key":"10.1016\/j.vaccine.2013.02.051_bib0105","article-title":"A Neonatal Mouse Model of Coxsackievirus A16 for Vaccine Evaluation","author":"Mao","year":"2012","journal-title":"J Virol"},{"issue":"Oct (47)","key":"10.1016\/j.vaccine.2013.02.051_bib0110","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"issue":"Apr (1)","key":"10.1016\/j.vaccine.2013.02.051_bib0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2013.02.051_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.antiviral.2008.06.017","article-title":"Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16","volume":"80","author":"Wu","year":"2008","journal-title":"Antiviral Res"},{"issue":"18","key":"10.1016\/j.vaccine.2013.02.051_bib0125","doi-asserted-by":"crossref","first-page":"7537","DOI":"10.1073\/pnas.0902749106","article-title":"Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity","volume":"106","author":"Zhang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Mar (14)","key":"10.1016\/j.vaccine.2013.02.051_bib0130","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1016\/j.vaccine.2005.12.024","article-title":"Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice","volume":"24","author":"Huang","year":"2006","journal-title":"Vaccine"},{"issue":"Jul (4)","key":"10.1016\/j.vaccine.2013.02.051_bib0135","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7883\/yoken.JJID.2009.254","article-title":"Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007","volume":"62","author":"Iwai","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"Dec (5\u20136)","key":"10.1016\/j.vaccine.2013.02.051_bib0140","first-page":"895","article-title":"Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus","volume":"20","author":"Wu","year":"2002","journal-title":"Vaccine"},{"issue":"Sep (11)","key":"10.1016\/j.vaccine.2013.02.051_bib0145","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.micinf.2007.06.002","article-title":"Passive protection against lethal enterovirus 71 infection in newborn mice by neutralizing antibodies elicited by a synthetic peptide","volume":"9","author":"Foo","year":"2007","journal-title":"Microbes Infect"},{"issue":"Apr (1)","key":"10.1016\/j.vaccine.2013.02.051_bib0150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virusres.2006.12.005","article-title":"Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides","volume":"125","author":"Foo","year":"2007","journal-title":"Virus Res"},{"issue":"Jun (26)","key":"10.1016\/j.vaccine.2013.02.051_bib0155","doi-asserted-by":"crossref","first-page":"4362","DOI":"10.1016\/j.vaccine.2011.04.010","article-title":"Identification and characterization of a cross-neutralization epitope of Enterovirus 71","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"issue":"Nov (49)","key":"10.1016\/j.vaccine.2013.02.051_bib0160","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1016\/j.vaccine.2012.09.030","article-title":"Cross-reactive neutralizing antibody epitopes against Enterovirus 71 identified by an in silico approach","volume":"30","author":"Kirk","year":"2012","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.02.051_bib0165","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nsmb.2255","article-title":"A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71","volume":"19","author":"Wang","year":"2012","journal-title":"Nat Struct Mol Biol"},{"issue":"Jun (6086)","key":"10.1016\/j.vaccine.2013.02.051_bib0170","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.1218713","article-title":"Crystal structure of human enterovirus 71","volume":"336","author":"Plevka","year":"2012","journal-title":"Science"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2013.02.051_bib0175","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jmv.10306","article-title":"Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans","volume":"69","author":"Harkonen","year":"2003","journal-title":"J Med Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.051_bib0180","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/db10-0057","article-title":"Enterovirus infection of human beta-cells activates dendritic cells and triggers innate antiviral responses: are enteroviruses convicted now?","volume":"59","author":"Christen","year":"2010","journal-title":"Diabetes"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2013.02.051_bib0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db11-1157","article-title":"Type 1 diabetes is associated with enterovirus infection in gut mucosa","volume":"61","author":"Oikarinen","year":"2012","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.vaccine.2013.02.051_bib0190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nrd2224","article-title":"More than one reason to rethink the use of peptides in vaccine design","volume":"6","author":"Purcell","year":"2007","journal-title":"Nat Rev Drug Discov"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13002405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,30]],"date-time":"2023-06-30T06:40:39Z","timestamp":1688107239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13002405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0264410X13002405"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.02.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}